19 Apr
0
This post was originally published on this site
Shire rejected Takeda’s $US60 billion takeover bid on Thursday, and now Allergan’s reportedly entering the bidding war. The $US60 billion bid was a 50% premium to Shire’s stock price on March 27, the day before Takeda initially approached Shire.
More »